Cargando…
Roles of CD4+ T cells as mediators of antitumor immunity
It has been well established that CD8+ T cells serve as effector cells of the adaptive immune response against tumors, whereas CD4+ T cells either help or suppress the generation of CD8+ cytotoxic T cells. However, in several experimental models as well as in cancer patients, it has been shown that...
Autores principales: | Kravtsov, Dmitriy S., Erbe, Amy K., Sondel, Paul M., Rakhmilevich, Alexander L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500154/ https://www.ncbi.nlm.nih.gov/pubmed/36159781 http://dx.doi.org/10.3389/fimmu.2022.972021 |
Ejemplares similares
-
NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy
por: Wang, Wei, et al.
Publicado: (2015) -
Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5- fluorouracil chemotherapy in the B16 melanoma model
por: Rakhmilevich, Alexander, et al.
Publicado: (2013) -
Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model
por: Carlson, Peter M, et al.
Publicado: (2021) -
In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response
por: Baniel, Claire C., et al.
Publicado: (2020) -
Regulation of CD8(+) T Cells and Antitumor Immunity by Notch Signaling
por: Tsukumo, Shin-ichi, et al.
Publicado: (2018)